115 related articles for article (PubMed ID: 35147967)
21. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
[TBL] [Abstract][Full Text] [Related]
22. Asleep Robot-Assisted Surgery for the Implantation of Subthalamic Electrodes Provides the Same Clinical Improvement and Therapeutic Window as Awake Surgery.
Lefranc M; Zouitina Y; Tir M; Merle P; Ouendo M; Constans JM; Godefroy O; Peltier J; Krystkowiak P
World Neurosurg; 2017 Oct; 106():602-608. PubMed ID: 28735132
[TBL] [Abstract][Full Text] [Related]
23. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
24. Electrode position and the clinical outcome after bilateral subthalamic nucleus stimulation.
Paek SH; Lee JY; Kim HJ; Kang D; Lim YH; Kim MR; Kim C; Jeon BS; Kim DG
J Korean Med Sci; 2011 Oct; 26(10):1344-55. PubMed ID: 22022189
[TBL] [Abstract][Full Text] [Related]
25. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
[TBL] [Abstract][Full Text] [Related]
26. Remotely Programmed Deep Brain Stimulation of the Bilateral Subthalamic Nucleus for the Treatment of Primary Parkinson Disease: A Randomized Controlled Trial Investigating the Safety and Efficacy of a Novel Deep Brain Stimulation System.
Li D; Zhang C; Gault J; Wang W; Liu J; Shao M; Zhao Y; Zeljic K; Gao G; Sun B
Stereotact Funct Neurosurg; 2017; 95(3):174-182. PubMed ID: 28571034
[TBL] [Abstract][Full Text] [Related]
27. Lack of differential motor outcome with subthalamic nucleus region stimulation in Parkinson's disease.
Kasasbeh A; Abulseoud OA; Matsumoto JY; Stead SM; Goerss SJ; Klassen BT; Huston J; Min HK; Lee KH; Frye MA
J Clin Neurosci; 2013 Nov; 20(11):1520-6. PubMed ID: 23906524
[TBL] [Abstract][Full Text] [Related]
28. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
[TBL] [Abstract][Full Text] [Related]
30. Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease.
Paff M; Wang AS; Phielipp N; Vadera S; Morenkova A; Hermanowicz N; Hsu FPK
J Robot Surg; 2020 Aug; 14(4):559-565. PubMed ID: 31520275
[TBL] [Abstract][Full Text] [Related]
31. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
[TBL] [Abstract][Full Text] [Related]
32. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
Brodsky MA; Anderson S; Murchison C; Seier M; Wilhelm J; Vederman A; Burchiel KJ
Neurology; 2017 Nov; 89(19):1944-1950. PubMed ID: 28986415
[TBL] [Abstract][Full Text] [Related]
34. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
[TBL] [Abstract][Full Text] [Related]
35. Bilateral subthalamic deep brain stimulation is an effective and safe treatment option for the older patients with Parkinson's disease.
Kim M; Cho KR; Park JH; Ahn JH; Cho JW; Park S; Lee JI; Youn J
Clin Neurol Neurosurg; 2018 Oct; 173():182-186. PubMed ID: 30149306
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcome of "Asleep" Deep Brain Stimulation for Parkinson Disease Using Robot-Assisted Delivery and Anatomic Targeting of the Subthalamic Nucleus: A Series of 152 Patients.
Moran CH; Pietrzyk M; Sarangmat N; Gerard CS; Barua N; Ashida R; Whone A; Szewczyk-Krolikowski K; Mooney L; Gill SS
Neurosurgery; 2020 Dec; 88(1):165-173. PubMed ID: 32985669
[TBL] [Abstract][Full Text] [Related]
37. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
[TBL] [Abstract][Full Text] [Related]
38. The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.
Sung VW; Watts RL; Schrandt CJ; Guthrie S; Wang D; Amara AW; Guthrie BL; Walker HC
J Neurosurg; 2013 Dec; 119(6):1530-6. PubMed ID: 24074493
[TBL] [Abstract][Full Text] [Related]
39. Asleep Surgery May Improve the Therapeutic Window for Deep Brain Stimulation of the Subthalamic Nucleus.
Senemmar F; Hartmann CJ; Slotty PJ; Vesper J; Schnitzler A; Groiss SJ
Neuromodulation; 2021 Feb; 24(2):279-285. PubMed ID: 32662156
[TBL] [Abstract][Full Text] [Related]
40. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
